This prospective study investigates the relationship between glucose transporter-1 (Glut-1)
expression and PET images using 18F-FDG and its uptake and compares them with the …

Positron emission tomography (PET) with [18 F] 2-fluoro-2-deoxy-D-glucose (FDG) may
show negative results for bronchioloalveolar lung carcinoma. We investigated the …

Increased glycolysis is a characteristic metabolic feature of a malig nant transformed
phenotype. In cultured cells transformed by vi ruses or activated oncogenes, enhanced …

Purpose: To examine the relationship between glucose transporter-1 (GLUT-1) and vascular
endothelial growth factor (VEGF) expression and 18 F-FDG uptake in esophageal …

Increased expression of glucose transporter-1 (Glut-1) and glucose transporter-3 (Glut-3)
has been reported in many human cancers. The mechanism of glucose entry into oral …

BACKGROUND: This study aimed to evaluate the variation in cervical cancer glucose
metabolism for different tumor histologies and levels of differentiation, as measured by the …

To clarify the biological significance of [18 F] fluorodeoxyglucose (18 F-FDG) accumulation
in patients with cancer, we assessed the relationships between 18 F-FDG uptake and …

The aim of the study was to investigate the pattern of glucose transporter-1 (Glut-1)
expression in primary and recurrent head and neck squamous cell carcinomas (HNSCCAs) …

AIM: To evaluate the correlation between the level of 18 F-fluoro-2-deoxyglucose (18 F-
FDG) uptake and glucose transporter 1 (GLUT1) expression in colorectal adenocarcinoma …

Objective: Glucose transporter type 1 (Glut1) has been reported to be present in several
types of carcinomas. The aims of this study are to evaluate Glut1 expression in both primary …